Science ❯ Medical Research ❯ Clinical Trials

Drug Development

Eli Lilly FDA Approvals Autism Research NRTIs and Alzheimer's Pembrolizumab Regulatory T Cells Health Innovations Neurodevelopmental Disorders Innovative Treatments HIV Research Covid-19 Treatments Health Outcomes Innovative Therapies Historical Context Patient Care Weight Loss Treatments Immunotherapy Drugs Obesity Research Efficacy Studies Oral Selective Oestrogen Receptor Degraders Larazotide EGFR Mutations Schizophrenia Treatments Oncology Monoclonal Antibodies

Tufts Chemists Unveil Four-Receptor Obesity Drug to Challenge Bariatric Surgery

The novel therapy’s four-receptor approach promises to mirror surgery outcomes with improved tolerability.

Blog Terms of Service Privacy Policy Help Partners About Us

Copyright © 2026 Mina Labs Inc.